Pharmaceuticals Learning the Language of the New Healthcare Landscape
With monumental health reform coming into effect, the pharmaceutical industry is learning to speak a second language. Clinical efficacy is no longer the sole...
Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis
Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to...
Rosetta Genomics Announces Agreement With Global Pharmaceutical Company to Advance Efforts in Alzheimer’s Disease Diagnostics
Rosetta Genomics Announces Agreement With Global Pharmaceutical Company to Advance Efforts in Alzheimer's Disease Diagnostics. Leverages Rosetta's microRNA Biomarker Platform and Expertise and Global...
FDA approves Bayer’s Eylea to treat diabetic macular edema
Bayer has announced the US Food and Drug Administration's (FDA) approval of Eylea, an aflibercept solution for injection into the eye for the treatment...
Enhancing Clinical Trial Success Rate Using eClinical Adaptive Trials Download
Vsoft Infoware has released a white paper entitled 'Enhancing Clinical Trial Success Rates Using eClinical Adaptive Trials', which discusses improving the success rate of...
KAE609 shows promise as next generation treatment for malaria
KAE609 is the first antimalarial drug candidate with a novel mechanism of action to achieve positive clinical proof-of-concept in over 20 years
KAE609 was tested...
QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients
Collaboration aims to create and commercialize companion diagnostic using genomic data from plasma samples to guide the use of IRESSA for non-small cell...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...